Slingshot Insights

Catalyst

Slingshot members are tracking this event:

EMA Decision on Regulatory Filings for Empliciti for Approval in Europe Due by April 1

Source Link:: http://d1lge852tjjqow.cloudfront.net/CIK-0000014272/e9b46f5e-5aac-4235-a465-d6d35bb1aa20.pdf?noexit=true

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

BMY

100%

ABBV

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details In January 2016, CHMP adopted a positive opinion on Empliciti on treatment of multiple myeloma for approval in Europe. The European Medicines Agency is required to make a decision by the end of March 2016.

http://d1lge852tjjqo...

Slingshot Insights Explained

JOIN FOR FREE TODAY

Catalyst Date

Occurred on:

May 11, 2016

Occurred Source:

http://www.businesswire.com/news/home/20160511006406/en/Bristol-Myers-Squibb-AbbVie-Announce-European-Commission-Approval

Related Projects

Don’t see a project related to the catalyst you care about?

Related Keywords Multiple Myeloma, Empliciti, Ema Decision, Maa, Elotuzumab